↓ Skip to main content

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

Overview of attention for article published in Molecular Cancer, July 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

policy
1 policy source
patent
2 patents

Citations

dimensions_citation
274 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
Published in
Molecular Cancer, July 2010
DOI 10.1186/1476-4598-9-188
Pubmed ID
Authors

Xuchao Zhang, Shirley Zhang, Xuening Yang, Jinji Yang, Qing Zhou, Lucy Yin, Shejuan An, Jiaying Lin, Shiliang Chen, Zhi Xie, Mike Zhu, Xiaolin Zhang, Yi-long Wu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
India 1 <1%
Germany 1 <1%
Japan 1 <1%
United Kingdom 1 <1%
Unknown 107 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 22%
Student > Ph. D. Student 16 14%
Other 10 9%
Student > Bachelor 10 9%
Student > Master 10 9%
Other 25 22%
Unknown 18 16%
Readers by discipline Count As %
Medicine and Dentistry 36 32%
Agricultural and Biological Sciences 27 24%
Biochemistry, Genetics and Molecular Biology 18 16%
Immunology and Microbiology 2 2%
Economics, Econometrics and Finance 2 2%
Other 3 3%
Unknown 26 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2023.
All research outputs
#4,734,949
of 22,947,506 outputs
Outputs from Molecular Cancer
#326
of 1,726 outputs
Outputs of similar age
#19,761
of 95,415 outputs
Outputs of similar age from Molecular Cancer
#5
of 23 outputs
Altmetric has tracked 22,947,506 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,726 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,415 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.